#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metastatic malignant melanoma Chronic graft versus host disease in skin Anti-neutrophil cytoplasmic antibody positive vasculitis Lupus nephritis Congenital leptin deficiency C3 glomerulopathy Frostbite Dermatitis Crigler-Najjar syndrome Idiopathic pulmonary fibrosis Leukocyte adhesion deficiency type I Small for dates baby Ischaemic stroke Bulbospinal muscular atrophy congenital Medulloblastoma recurrent More trials…

    Learn about Rare Diseases

    Antithrombin III deficiency – Treatment Primary mediastinal large B-cell lymphoma – Trials in Disease Richter’s syndrome – Treatment Osteosarcoma recurrent Lysosomal storage disorder – Life with Disease Hereditary ataxia – Basic Information Paraneoplastic neurological syndrome – Life with Disease Toxic epidermal necrolysis – Diagnostics Basal cell naevus syndrome – Life with Disease Chordoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tedizolid Phosphate Utreglutide OMEGA-3-ACID ETHYL ESTERS 90 Mbf-118 Desvenlafaxine Benzoate Tafamidis Calcium Chloride Hexahydrate GRNA1599 Imatinib Gs-1427 Gallium (68Ga) Chloride Prs-344 Jnj-64042056 Norfloxacin Sodium Iotalamate (125I) BI 456906 Niraparib Tosilate Monohydrate Zofenopril Calcium CANNABINOL Taplucainium Chloride More therapies…

    Learn about Your Condition

    Asplenia Lung disorder Adrenal insufficiency Metastases to meninges Catatonia Postoperative delirium Endometrial cancer stage III Colon cancer stage III Neoplasm Osteogenesis imperfecta Synovitis Obliterative bronchiolitis Ischaemic skin ulcer Endometrial cancer stage I Chronic coronary syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study comparing AZD0486 after reduced chemotherapy versus standard chemotherapy in older or unfit patients with newly diagnosed large B-cell lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
    • Pegfilgrastim
    • Cyclophosphamide
    Belgium Poland

  • A Study Testing the Safety of LTX-002 Sodium Given into the Spinal Canal in Adults with Amyotrophic Lateral Sclerosis

    Recruiting

    2 1
    Investigated Drugs:
    • LTX-002 SODIUM
    Germany Italy The Netherlands Sweden

  • A study comparing macrogol 3350 combination and sodium picosulfate for bowel cleansing before colonoscopy in children and teenagers with colonic disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Macrogol 3350
    • Sodium Ascorbate
    • Sodium Picosulfate
    Belgium Croatia Germany Hungary Italy The Netherlands +3

  • A Study of VGA039 to Prevent Bleeding in Teenagers and Adults with von Willebrand Disease Who Have Not Used Regular Preventive Treatment Before

    Recruiting

    3 1 1
    Investigated Drugs:
    • VGA039
    Austria Finland Germany Ireland Italy

  • A Study of ROC-101 Hydrochloride for Patients with Pulmonary Arterial Hypertension and Pulmonary Hypertension Associated with Interstitial Lung Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • ROC-101 HYDROCHLORIDE
    France Germany Italy Latvia Poland Spain

  • A study comparing brelovitug to bulevirtide for treating chronic hepatitis delta infection in patients currently receiving bulevirtide

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatitis D
    Investigated Drugs:
    • Bjt-778
    • Bulevirtide
    Austria Czechia France Germany Italy Romania +1
Previous Page
1 … 63 64 65 66 67 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!